Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Wrong- it does alter the science. Consider this: what if B were already established as a beneficial treatment for some segment of COVID patients? Then some enterprising researcher would need to include it in their Corona trial, since it would be standard of care.

Turn the tables: someone would have to show that Dexamethasone provided additional benefit to B for hospitalized patients that were helped by it.

Instead of the other way around, right? or will they just have to select hospitalized patients not yet on decadron?

How many other agents might be in the mix by the time the trial is ever done?

If B were standard of care it could alter the science of the trials